Home Based Electrical Stimulation on Post-stroke Lower Limb Tightness.
The Feasibility and Impact of A Home-Based NMES Program on Post-Stroke Lower Limb Spasticity
1 other identifier
interventional
20
1 country
1
Brief Summary
Spasticity is a common complication post stroke. Post-stroke spasticity along with weakness and lack of coordination result in gait abnormalities and functional limitations. Recent treatment option include neuromuscular electric stimulation (NMES), a form of therapy that applies electrical currents to produce contraction of innervated muscle by depolarizing local motor nerves. Currently, there are wide varieties of NMES devices available commercially for consumer. The main purpose of this study is to evaluate the feasibility and acceptability of a home-based NMES program on lower limb spasticity in patient with post-stroke more than 6 months and to assess the impact of the program. This is single arm prospective intervention study. Patient will apply home-based NMES on their leg for 20 minutes, 5 days a week for 4 weeks. At the end of the study, an outcome measures will be assessed and patient will be required to answer a questionnaires on their experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2020
CompletedFirst Submitted
Initial submission to the registry
June 6, 2021
CompletedFirst Posted
Study publicly available on registry
June 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedJune 21, 2021
June 1, 2021
9 months
June 6, 2021
June 12, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Retention Rate
The proportion of patients who completed the program. Patient completed divided with patient recruited, expressed in percentage (%).
4 weeks
Acceptability
Acceptability as evaluated at the end of the intervention by brief structured questionnaire developed for this study using 5 point Likert scale with 1 (strongly agree) and 5 (strongly agree).
4 weeks
Secondary Outcomes (4)
Clinical measurement of spasticity
4 weeks (pre and post assessment)
Clinical measurement of spasticity
4 weeks (pre and post assessment)
Ankle dorsiflexion muscle strength
4 weeks (pre and post assessment)
Functional Outcome
4 weeks (pre and post assessment)
Study Arms (1)
Home-based Electrical Stimulation Program for lower limb spasticity
EXPERIMENTALSingle arm prospective intervention study to assess the feasibility and impact of a home-based program. Patient will apply home-based NMES on their leg for 20 minutes, 5 days a week for 4 weeks. At the end of the study, an outcome measures will be assessed and patient will be required to answer a questionnaires on their experience.
Interventions
Home-based NMES program on spastic leg. The NMES pre-programmed dosage (locked): NMES waveform is biphasic PC, Frequency 50Hz, pulse width 400µs, ON:OFF 10s:20s and current amplitude: individual maximum tolerated to achieve ankle dorsiflexion.
Eligibility Criteria
You may qualify if:
- Post stroke (hemorrhagic or ischemic) with ankle plantarflexor (gastrocnemius and soleus) spasticity MAS 1+ to MAS 3,
- Post stroke more than 6 months,
- At least 18 years old,
- Able to ambulate 10 meter either independently or aided (single point stick or quadripod)
- Compliant to outpatient therapy.
- Minimal cognitive (MMSE\> 24) and minimal sensory impairment,
- Stable neurological and medical condition
You may not qualify if:
- Introduction or changes in anti-spastic medication dose within 3 months or during study period,
- Receiving intervention for spasticity (eg BoNT or serial casting) within 3 months or during research period,
- New neurological condition/disease,
- Presence of contraindications to NMES, which is: Pregnancy, Malignancy, Presence of electronic implant eg cardiac pacemaker, cardioverter defibrillator, Uncontrolled seizure/epilepsy, Infected tissues/ tuberculosis or osteomyelitis, Impaired lower limb circulation/ DVT/ thrombophlebitis, Recent fracture or osteoporosis, Actively bleeding tissue or person with untreated hemorrhagic disorder, Damaged or skin diseases at the affected lower limb
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Malaya Medical Center
Kuala Lumpur, 59100, Malaysia
Study Officials
- PRINCIPAL INVESTIGATOR
Raja Nabila BT Raja Mohamed Anuar
University Malaya Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor, Principal Investigator
Study Record Dates
First Submitted
June 6, 2021
First Posted
June 21, 2021
Study Start
November 5, 2020
Primary Completion
August 1, 2021
Study Completion
February 1, 2022
Last Updated
June 21, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share